APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ultrasonic Microbubble Contrast Agents

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ultrasonic Microbubble Contrast Agents Industry Growth and Trends Forecast to 2032

27 December 2025114 pages

Choose your research edition.

Industry ResearchUltrasonic Microbubble Contrast Agents Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Ultrasonic Microbubble Contrast Agents Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Ultrasonic Microbubble Contrast Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ultrasonic Microbubble Contrast Agents Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Ultrasonic Microbubble Contrast Agents Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Ultrasonic Microbubble Contrast Agents market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ultrasonic Microbubble Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ultrasonic Microbubble Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ultrasonic Microbubble Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ultrasonic Microbubble Contrast Agents include Bayer, Bracco, GE Healthcare, ImaRx Therapeutics, Lantheus Medical Imaging, Microvascular Therapeutics, Miltenyi Biotec, NanoPET Pharma and POINTbiomedical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ultrasonic Microbubble Contrast Agents market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ultrasonic Microbubble Contrast Agents market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ultrasonic Microbubble Contrast Agents market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ultrasonic Microbubble Contrast Agents.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ultrasonic Microbubble Contrast Agents market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ultrasonic Microbubble Contrast Agents Market by Company

Bayer

Bracco

GE Healthcare

ImaRx Therapeutics

Lantheus Medical Imaging

Microvascular Therapeutics

Miltenyi Biotec

NanoPET Pharma

POINTbiomedical

Feiruida Medical

Fuman Group

Runkun Pharmaceutical

Lizhuo Pharmaceutical

Qi-hui Biopharmaceutical

SUNΛ Med-Engineering

Starleaf

Ultrasonic Microbubble Contrast Agents Segment by Type

Liposome Envelope

Multimer-based Envelope

Albumin-based Envelope

Others

Ultrasonic Microbubble Contrast Agents Segment by Application

Angiographic Ultrasonography

Cardiac Ultrasonography

Liver Ultrasonography

Others

Ultrasonic Microbubble Contrast Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ultrasonic Microbubble Contrast Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ultrasonic Microbubble Contrast Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ultrasonic Microbubble Contrast Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ultrasonic Microbubble Contrast Agents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ultrasonic Microbubble Contrast Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Liposome Envelope Table 2. Major Company of Multimer-based Envelope Table 3. Major Company of Albumin-based Envelope Table 4. Major Company of Others Table 5. Global Ultrasonic Microbubble Contrast Agents Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2026) & (Units) Table 7. Global Ultrasonic Microbubble Contrast Agents Sales Market Share in Volume by Type (2021-2026) Table 8. Global Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2026) & (US$ Million) Table 9. Global Ultrasonic Microbubble Contrast Agents Sales Market Share in Value by Type (2021-2026) Table 10. Global Ultrasonic Microbubble Contrast Agents Price by Type (2021-2026) & (US$/Unit) Table 11. Global Ultrasonic Microbubble Contrast Agents Sales by Type (2027-2032) & (Units) Table 12. Global Ultrasonic Microbubble Contrast Agents Sales Market Share in Volume by Type (2027-2032) Table 13. Global Ultrasonic Microbubble Contrast Agents Sales by Type (2027-2032) & (US$ Million) Table 14. Global Ultrasonic Microbubble Contrast Agents Sales Market Share in Value by Type (2027-2032) Table 15. Global Ultrasonic Microbubble Contrast Agents Price by Type (2027-2032) & (US$/Unit) Table 16. North America Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2026) & (Units) Table 17. North America Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2026) & (Units) Table 19. Europe Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2026) & (Units) Table 21. Asia-Pacific Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2026) & (Units) Table 23. Latin America Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2026) & (Units) Table 25. Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2026) & (US$ Million) Table 26. Ultrasonic Microbubble Contrast Agents Industry Trends Table 27. Ultrasonic Microbubble Contrast Agents Industry Drivers Table 28. Ultrasonic Microbubble Contrast Agents Industry Opportunities and Challenges Table 29. Ultrasonic Microbubble Contrast Agents Industry Restraints Table 30. Global Ultrasonic Microbubble Contrast Agents Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Ultrasonic Microbubble Contrast Agents Revenue Market Share by Company (2021-2026) Table 32. Global Ultrasonic Microbubble Contrast Agents Sales by Company (2021-2026) & (Units) Table 33. Global Ultrasonic Microbubble Contrast Agents Sales Share by Company (2021-2026) Table 34. Global Ultrasonic Microbubble Contrast Agents Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Ultrasonic Microbubble Contrast Agents Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Ultrasonic Microbubble Contrast Agents Major Company Production Sites and Headquarters Table 37. Global Ultrasonic Microbubble Contrast Agents Company, Product Type & Application Table 38. Global Ultrasonic Microbubble Contrast Agents Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Ultrasonic Microbubble Contrast Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Ultrasonic Microbubble Contrast Agents Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Ultrasonic Microbubble Contrast Agents Sales by Region (2021-2026) & (Units) Table 43. Global Ultrasonic Microbubble Contrast Agents Sales Market Share in Volume by Region (2021-2026) Table 44. Global Ultrasonic Microbubble Contrast Agents Sales by Region (2021-2026) & (US$ Million) Table 45. Global Ultrasonic Microbubble Contrast Agents Sales Market Share in Value by Region (2021-2026) Table 46. Global Ultrasonic Microbubble Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Ultrasonic Microbubble Contrast Agents Sales by Region (2027-2032) & (Units) Table 48. Global Ultrasonic Microbubble Contrast Agents Sales Market Share in Volume by Region (2027-2032) Table 49. Global Ultrasonic Microbubble Contrast Agents Sales by Region (2027-2032) & (US$ Million) Table 50. Global Ultrasonic Microbubble Contrast Agents Sales Market Share in Value by Region (2027-2032) Table 51. Global Ultrasonic Microbubble Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Ultrasonic Microbubble Contrast Agents Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Ultrasonic Microbubble Contrast Agents Sales by Application (2021-2026) & (Units) Table 54. Global Ultrasonic Microbubble Contrast Agents Sales Market Share in Volume by Application (2021-2026) Table 55. Global Ultrasonic Microbubble Contrast Agents Sales by Application (2021-2026) & (US$ Million) Table 56. Global Ultrasonic Microbubble Contrast Agents Sales Market Share in Value by Application (2021-2026) Table 57. Global Ultrasonic Microbubble Contrast Agents Price by Application (2021-2026) & (US$/Unit) Table 58. Global Ultrasonic Microbubble Contrast Agents Sales by Application (2027-2032) & (Units) Table 59. Global Ultrasonic Microbubble Contrast Agents Sales Market Share in Volume by Application (2027-2032) Table 60. Global Ultrasonic Microbubble Contrast Agents Sales by Application (2027-2032) & (US$ Million) Table 61. Global Ultrasonic Microbubble Contrast Agents Sales Market Share in Value by Application (2027-2032) Table 62. Global Ultrasonic Microbubble Contrast Agents Price by Application (2027-2032) & (US$/Unit) Table 63. North America Ultrasonic Microbubble Contrast Agents Sales by Application (2021-2026) & (Units) Table 64. North America Ultrasonic Microbubble Contrast Agents Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Ultrasonic Microbubble Contrast Agents Sales by Application (2021-2026) & (Units) Table 66. Europe Ultrasonic Microbubble Contrast Agents Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Ultrasonic Microbubble Contrast Agents Sales by Application (2021-2026) & (Units) Table 68. Asia-Pacific Ultrasonic Microbubble Contrast Agents Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Ultrasonic Microbubble Contrast Agents Sales by Application (2021-2026) & (Units) Table 70. Latin America Ultrasonic Microbubble Contrast Agents Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales by Application (2021-2026) & (Units) Table 72. Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales by Application (2021-2026) & (US$ Million) Table 73. Bayer Company Information Table 74. Bayer Business Overview Table 75. Bayer Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Bayer Ultrasonic Microbubble Contrast Agents Product Portfolio Table 77. Bayer Recent Development Table 78. Bracco Company Information Table 79. Bracco Business Overview Table 80. Bracco Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Bracco Ultrasonic Microbubble Contrast Agents Product Portfolio Table 82. Bracco Recent Development Table 83. GE Healthcare Company Information Table 84. GE Healthcare Business Overview Table 85. GE Healthcare Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. GE Healthcare Ultrasonic Microbubble Contrast Agents Product Portfolio Table 87. GE Healthcare Recent Development Table 88. ImaRx Therapeutics Company Information Table 89. ImaRx Therapeutics Business Overview Table 90. ImaRx Therapeutics Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. ImaRx Therapeutics Ultrasonic Microbubble Contrast Agents Product Portfolio Table 92. ImaRx Therapeutics Recent Development Table 93. Lantheus Medical Imaging Company Information Table 94. Lantheus Medical Imaging Business Overview Table 95. Lantheus Medical Imaging Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Lantheus Medical Imaging Ultrasonic Microbubble Contrast Agents Product Portfolio Table 97. Lantheus Medical Imaging Recent Development Table 98. Microvascular Therapeutics Company Information Table 99. Microvascular Therapeutics Business Overview Table 100. Microvascular Therapeutics Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Microvascular Therapeutics Ultrasonic Microbubble Contrast Agents Product Portfolio Table 102. Microvascular Therapeutics Recent Development Table 103. Miltenyi Biotec Company Information Table 104. Miltenyi Biotec Business Overview Table 105. Miltenyi Biotec Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Miltenyi Biotec Ultrasonic Microbubble Contrast Agents Product Portfolio Table 107. Miltenyi Biotec Recent Development Table 108. NanoPET Pharma Company Information Table 109. NanoPET Pharma Business Overview Table 110. NanoPET Pharma Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. NanoPET Pharma Ultrasonic Microbubble Contrast Agents Product Portfolio Table 112. NanoPET Pharma Recent Development Table 113. POINTbiomedical Company Information Table 114. POINTbiomedical Business Overview Table 115. POINTbiomedical Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. POINTbiomedical Ultrasonic Microbubble Contrast Agents Product Portfolio Table 117. POINTbiomedical Recent Development Table 118. Feiruida Medical Company Information Table 119. Feiruida Medical Business Overview Table 120. Feiruida Medical Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Feiruida Medical Ultrasonic Microbubble Contrast Agents Product Portfolio Table 122. Feiruida Medical Recent Development Table 123. Fuman Group Company Information Table 124. Fuman Group Business Overview Table 125. Fuman Group Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Fuman Group Ultrasonic Microbubble Contrast Agents Product Portfolio Table 127. Fuman Group Recent Development Table 128. Runkun Pharmaceutical Company Information Table 129. Runkun Pharmaceutical Business Overview Table 130. Runkun Pharmaceutical Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Runkun Pharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolio Table 132. Runkun Pharmaceutical Recent Development Table 133. Lizhuo Pharmaceutical Company Information Table 134. Lizhuo Pharmaceutical Business Overview Table 135. Lizhuo Pharmaceutical Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Lizhuo Pharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolio Table 137. Lizhuo Pharmaceutical Recent Development Table 138. Qi-hui Biopharmaceutical Company Information Table 139. Qi-hui Biopharmaceutical Business Overview Table 140. Qi-hui Biopharmaceutical Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Qi-hui Biopharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolio Table 142. Qi-hui Biopharmaceutical Recent Development Table 143. SUNΛ Med-Engineering Company Information Table 144. SUNΛ Med-Engineering Business Overview Table 145. SUNΛ Med-Engineering Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. SUNΛ Med-Engineering Ultrasonic Microbubble Contrast Agents Product Portfolio Table 147. SUNΛ Med-Engineering Recent Development Table 148. Starleaf Company Information Table 149. Starleaf Business Overview Table 150. Starleaf Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Starleaf Ultrasonic Microbubble Contrast Agents Product Portfolio Table 152. Starleaf Recent Development Table 153. North America Ultrasonic Microbubble Contrast Agents Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 154. North America Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2026) & (Units) Table 155. North America Ultrasonic Microbubble Contrast Agents Sales Market Share by Country (2021-2026) Table 156. North America Ultrasonic Microbubble Contrast Agents Sales Forecast by Country (2027-2032) & (Units) Table 157. North America Ultrasonic Microbubble Contrast Agents Sales Market Share Forecast by Country (2027-2032) Table 158. North America Ultrasonic Microbubble Contrast Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. North America Ultrasonic Microbubble Contrast Agents Market Size by Country (2021-2026) & (US$ Million) Table 160. North America Ultrasonic Microbubble Contrast Agents Market Share by Country (2021-2026) Table 161. North America Ultrasonic Microbubble Contrast Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. North America Ultrasonic Microbubble Contrast Agents Market Share Forecast by Country (2027-2032) Table 163. Europe Ultrasonic Microbubble Contrast Agents Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 164. Europe Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2026) & (Units) Table 165. Europe Ultrasonic Microbubble Contrast Agents Sales Market Share by Country (2021-2026) Table 166. Europe Ultrasonic Microbubble Contrast Agents Sales Forecast by Country (2027-2032) & (Units) Table 167. Europe Ultrasonic Microbubble Contrast Agents Sales Market Share Forecast by Country (2027-2032) Table 168. Europe Ultrasonic Microbubble Contrast Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Europe Ultrasonic Microbubble Contrast Agents Market Size by Country (2021-2026) & (US$ Million) Table 170. Europe Ultrasonic Microbubble Contrast Agents Market Share by Country (2021-2026) Table 171. Europe Ultrasonic Microbubble Contrast Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Europe Ultrasonic Microbubble Contrast Agents Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2026) & (Units) Table 175. Asia-Pacific Ultrasonic Microbubble Contrast Agents Sales Market Share by Country (2021-2026) Table 176. Asia-Pacific Ultrasonic Microbubble Contrast Agents Sales Forecast by Country (2027-2032) & (Units) Table 177. Asia-Pacific Ultrasonic Microbubble Contrast Agents Sales Market Share Forecast by Country (2027-2032) Table 178. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size by Country (2021-2026) & (US$ Million) Table 180. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Share by Country (2021-2026) Table 181. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Share Forecast by Country (2027-2032) Table 183. Latin America Ultrasonic Microbubble Contrast Agents Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 184. Latin America Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2026) & (Units) Table 185. Latin America Ultrasonic Microbubble Contrast Agents Sales Market Share by Country (2021-2026) Table 186. Latin America Ultrasonic Microbubble Contrast Agents Sales Forecast by Country (2027-2032) & (Units) Table 187. Latin America Ultrasonic Microbubble Contrast Agents Sales Market Share Forecast by Country (2027-2032) Table 188. Latin America Ultrasonic Microbubble Contrast Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Latin America Ultrasonic Microbubble Contrast Agents Market Size by Country (2021-2026) & (US$ Million) Table 190. Latin America Ultrasonic Microbubble Contrast Agents Market Share by Country (2021-2026) Table 191. Latin America Ultrasonic Microbubble Contrast Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Latin America Ultrasonic Microbubble Contrast Agents Market Share Forecast by Country (2027-2032) Table 193. Middle East and Africa Ultrasonic Microbubble Contrast Agents Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 194. Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2026) & (Units) Table 195. Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales Market Share by Country (2021-2026) Table 196. Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales Forecast by Country (2027-2032) & (Units) Table 197. Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales Market Share Forecast by Country (2027-2032) Table 198. Middle East and Africa Ultrasonic Microbubble Contrast Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Middle East and Africa Ultrasonic Microbubble Contrast Agents Market Size by Country (2021-2026) & (US$ Million) Table 200. Middle East and Africa Ultrasonic Microbubble Contrast Agents Market Share by Country (2021-2026) Table 201. Middle East and Africa Ultrasonic Microbubble Contrast Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Middle East and Africa Ultrasonic Microbubble Contrast Agents Market Share Forecast by Country (2027-2032) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Ultrasonic Microbubble Contrast Agents Distributors List Table 206. Ultrasonic Microbubble Contrast Agents Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Ultrasonic Microbubble Contrast Agents Image Figure 2. Global Ultrasonic Microbubble Contrast Agents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ultrasonic Microbubble Contrast Agents Market Size (2021-2032) & (US$ Million) Figure 4. Global Ultrasonic Microbubble Contrast Agents Sales (2021-2032) & (Units) Figure 5. Liposome Envelope Image Figure 6. Global Liposome Envelope Sales YoY Growth (2021-2032) & (Units) Figure 7. Multimer-based Envelope Image Figure 8. Global Multimer-based Envelope Sales YoY Growth (2021-2032) & (Units) Figure 9. Albumin-based Envelope Image Figure 10. Global Albumin-based Envelope Sales YoY Growth (2021-2032) & (Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (Units) Figure 13. Global Ultrasonic Microbubble Contrast Agents Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Ultrasonic Microbubble Contrast Agents Market Share by Type 2025 VS 2032 Figure 15. North America Ultrasonic Microbubble Contrast Agents Sales Market Share in Volume by Type in 2025 Figure 16. North America Ultrasonic Microbubble Contrast Agents Sales Market Share in Value by Type in 2025 Figure 17. Europe Ultrasonic Microbubble Contrast Agents Sales Market Share in Volume by Type in 2025 Figure 18. Europe Ultrasonic Microbubble Contrast Agents Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Ultrasonic Microbubble Contrast Agents Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Ultrasonic Microbubble Contrast Agents Sales Market Share in Value by Type in 2025 Figure 21. Latin America Ultrasonic Microbubble Contrast Agents Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Ultrasonic Microbubble Contrast Agents Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Ultrasonic Microbubble Contrast Agents Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Angiographic Ultrasonography Image Figure 28. Global Angiographic Ultrasonography Sales YoY Growth (2021-2032) & (Units) Figure 29. Cardiac Ultrasonography Image Figure 30. Global Cardiac Ultrasonography Sales YoY Growth (2021-2032) & (Units) Figure 31. Liver Ultrasonography Image Figure 32. Global Liver Ultrasonography Sales YoY Growth (2021-2032) & (Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (Units) Figure 35. Global Ultrasonic Microbubble Contrast Agents Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Ultrasonic Microbubble Contrast Agents Market Share by Application 2025 VS 2032 Figure 37. North America Ultrasonic Microbubble Contrast Agents Sales Market Share in Volume by Application in 2025 Figure 38. North America Ultrasonic Microbubble Contrast Agents Sales Market Share in Value by Application in 2025 Figure 39. Europe Ultrasonic Microbubble Contrast Agents Sales Market Share in Volume by Application in 2025 Figure 40. Europe Ultrasonic Microbubble Contrast Agents Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Ultrasonic Microbubble Contrast Agents Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Ultrasonic Microbubble Contrast Agents Sales Market Share in Value by Application in 2025 Figure 43. Latin America Ultrasonic Microbubble Contrast Agents Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Ultrasonic Microbubble Contrast Agents Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales Market Share in Value by Application in 2025 Figure 47. North America Ultrasonic Microbubble Contrast Agents Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 48. North America Ultrasonic Microbubble Contrast Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Ultrasonic Microbubble Contrast Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Ultrasonic Microbubble Contrast Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Ultrasonic Microbubble Contrast Agents Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 52. Europe Ultrasonic Microbubble Contrast Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Ultrasonic Microbubble Contrast Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Ultrasonic Microbubble Contrast Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Ultrasonic Microbubble Contrast Agents Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 56. Asia-Pacific Ultrasonic Microbubble Contrast Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Ultrasonic Microbubble Contrast Agents Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 60. Latin America Ultrasonic Microbubble Contrast Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Ultrasonic Microbubble Contrast Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Ultrasonic Microbubble Contrast Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 64. Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Ultrasonic Microbubble Contrast Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Ultrasonic Microbubble Contrast Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Ultrasonic Microbubble Contrast Agents Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Ultrasonic Microbubble Contrast Agents Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Liposome Envelope
  • Multimer-based Envelope
  • Albumin-based Envelope
  • Others
Applications
  • Angiographic Ultrasonography
  • Cardiac Ultrasonography
  • Liver Ultrasonography
  • Others
Companies covered
  • Bayer
  • Bracco
  • GE Healthcare
  • ImaRx Therapeutics
  • Lantheus Medical Imaging
  • Microvascular Therapeutics
  • Miltenyi Biotec
  • NanoPET Pharma
  • POINTbiomedical
  • Feiruida Medical
  • Fuman Group
  • Runkun Pharmaceutical
  • Lizhuo Pharmaceutical
  • Qi-hui Biopharmaceutical
  • SUNΛ Med-Engineering
  • Starleaf

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ultrasonic Microbubble Contrast Agents Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ultrasonic Microbubble Contrast Agents Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ultrasonic Microbubble Contrast Agents Market by Type
  6. 1.3.1 Liposome Envelope
  7. 1.3.2 Multimer-based Envelope
  8. 1.3.3 Albumin-based Envelope
  9. 1.3.4 Others
  10. 1.4 Global Ultrasonic Microbubble Contrast Agents Market Size by Type
  11. 1.4.1 Global Ultrasonic Microbubble Contrast Agents Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Ultrasonic Microbubble Contrast Agents Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Ultrasonic Microbubble Contrast Agents Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Ultrasonic Microbubble Contrast Agents Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Ultrasonic Microbubble Contrast Agents Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Ultrasonic Microbubble Contrast Agents Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Ultrasonic Microbubble Contrast Agents Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ultrasonic Microbubble Contrast Agents Industry Trends
  2. 2.2 Ultrasonic Microbubble Contrast Agents Industry Drivers
  3. 2.3 Ultrasonic Microbubble Contrast Agents Industry Opportunities and Challenges
  4. 2.4 Ultrasonic Microbubble Contrast Agents Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ultrasonic Microbubble Contrast Agents Revenue (2021-2026)
  2. 3.2 Global Top Players by Ultrasonic Microbubble Contrast Agents Sales (2021-2026)
  3. 3.3 Global Top Players by Ultrasonic Microbubble Contrast Agents Price (2021-2026)
  4. 3.4 Global Ultrasonic Microbubble Contrast Agents Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ultrasonic Microbubble Contrast Agents Major Company Production Sites & Headquarters
  6. 3.6 Global Ultrasonic Microbubble Contrast Agents Company, Product Type & Application
  7. 3.7 Global Ultrasonic Microbubble Contrast Agents Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ultrasonic Microbubble Contrast Agents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ultrasonic Microbubble Contrast Agents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ultrasonic Microbubble Contrast Agents Tier 1, Tier 2, and Tier 3
4 Ultrasonic Microbubble Contrast Agents Regional Status and Outlook
  1. 4.1 Global Ultrasonic Microbubble Contrast Agents Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ultrasonic Microbubble Contrast Agents Historic Market Size by Region
  3. 4.2.1 Global Ultrasonic Microbubble Contrast Agents Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ultrasonic Microbubble Contrast Agents Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ultrasonic Microbubble Contrast Agents Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ultrasonic Microbubble Contrast Agents Forecasted Market Size by Region
  7. 4.3.1 Global Ultrasonic Microbubble Contrast Agents Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ultrasonic Microbubble Contrast Agents Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ultrasonic Microbubble Contrast Agents Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ultrasonic Microbubble Contrast Agents by Application
  1. 5.1 Ultrasonic Microbubble Contrast Agents Market by Application
  2. 5.1.1 Angiographic Ultrasonography
  3. 5.1.2 Cardiac Ultrasonography
  4. 5.1.3 Liver Ultrasonography
  5. 5.1.4 Others
  6. 5.2 Global Ultrasonic Microbubble Contrast Agents Market Size by Application
  7. 5.2.1 Global Ultrasonic Microbubble Contrast Agents Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Ultrasonic Microbubble Contrast Agents Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Ultrasonic Microbubble Contrast Agents Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Ultrasonic Microbubble Contrast Agents Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Ultrasonic Microbubble Contrast Agents Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Ultrasonic Microbubble Contrast Agents Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Ultrasonic Microbubble Contrast Agents Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bayer
  2. 6.1.1 Bayer Company Information
  3. 6.1.2 Bayer Business Overview
  4. 6.1.3 Bayer Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bayer Ultrasonic Microbubble Contrast Agents Product Portfolio
  6. 6.1.5 Bayer Recent Developments
  7. 6.2 Bracco
  8. 6.2.1 Bracco Company Information
  9. 6.2.2 Bracco Business Overview
  10. 6.2.3 Bracco Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bracco Ultrasonic Microbubble Contrast Agents Product Portfolio
  12. 6.2.5 Bracco Recent Developments
  13. 6.3 GE Healthcare
  14. 6.3.1 GE Healthcare Company Information
  15. 6.3.2 GE Healthcare Business Overview
  16. 6.3.3 GE Healthcare Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GE Healthcare Ultrasonic Microbubble Contrast Agents Product Portfolio
  18. 6.3.5 GE Healthcare Recent Developments
  19. 6.4 ImaRx Therapeutics
  20. 6.4.1 ImaRx Therapeutics Company Information
  21. 6.4.2 ImaRx Therapeutics Business Overview
  22. 6.4.3 ImaRx Therapeutics Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 ImaRx Therapeutics Ultrasonic Microbubble Contrast Agents Product Portfolio
  24. 6.4.5 ImaRx Therapeutics Recent Developments
  25. 6.5 Lantheus Medical Imaging
  26. 6.5.1 Lantheus Medical Imaging Company Information
  27. 6.5.2 Lantheus Medical Imaging Business Overview
  28. 6.5.3 Lantheus Medical Imaging Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Lantheus Medical Imaging Ultrasonic Microbubble Contrast Agents Product Portfolio
  30. 6.5.5 Lantheus Medical Imaging Recent Developments
  31. 6.6 Microvascular Therapeutics
  32. 6.6.1 Microvascular Therapeutics Company Information
  33. 6.6.2 Microvascular Therapeutics Business Overview
  34. 6.6.3 Microvascular Therapeutics Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Microvascular Therapeutics Ultrasonic Microbubble Contrast Agents Product Portfolio
  36. 6.6.5 Microvascular Therapeutics Recent Developments
  37. 6.7 Miltenyi Biotec
  38. 6.7.1 Miltenyi Biotec Company Information
  39. 6.7.2 Miltenyi Biotec Business Overview
  40. 6.7.3 Miltenyi Biotec Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Miltenyi Biotec Ultrasonic Microbubble Contrast Agents Product Portfolio
  42. 6.7.5 Miltenyi Biotec Recent Developments
  43. 6.8 NanoPET Pharma
  44. 6.8.1 NanoPET Pharma Company Information
  45. 6.8.2 NanoPET Pharma Business Overview
  46. 6.8.3 NanoPET Pharma Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 NanoPET Pharma Ultrasonic Microbubble Contrast Agents Product Portfolio
  48. 6.8.5 NanoPET Pharma Recent Developments
  49. 6.9 POINTbiomedical
  50. 6.9.1 POINTbiomedical Company Information
  51. 6.9.2 POINTbiomedical Business Overview
  52. 6.9.3 POINTbiomedical Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 POINTbiomedical Ultrasonic Microbubble Contrast Agents Product Portfolio
  54. 6.9.5 POINTbiomedical Recent Developments
  55. 6.10 Feiruida Medical
  56. 6.10.1 Feiruida Medical Company Information
  57. 6.10.2 Feiruida Medical Business Overview
  58. 6.10.3 Feiruida Medical Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Feiruida Medical Ultrasonic Microbubble Contrast Agents Product Portfolio
  60. 6.10.5 Feiruida Medical Recent Developments
  61. 6.11 Fuman Group
  62. 6.11.1 Fuman Group Company Information
  63. 6.11.2 Fuman Group Business Overview
  64. 6.11.3 Fuman Group Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Fuman Group Ultrasonic Microbubble Contrast Agents Product Portfolio
  66. 6.11.5 Fuman Group Recent Developments
  67. 6.12 Runkun Pharmaceutical
  68. 6.12.1 Runkun Pharmaceutical Company Information
  69. 6.12.2 Runkun Pharmaceutical Business Overview
  70. 6.12.3 Runkun Pharmaceutical Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Runkun Pharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolio
  72. 6.12.5 Runkun Pharmaceutical Recent Developments
  73. 6.13 Lizhuo Pharmaceutical
  74. 6.13.1 Lizhuo Pharmaceutical Company Information
  75. 6.13.2 Lizhuo Pharmaceutical Business Overview
  76. 6.13.3 Lizhuo Pharmaceutical Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Lizhuo Pharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolio
  78. 6.13.5 Lizhuo Pharmaceutical Recent Developments
  79. 6.14 Qi-hui Biopharmaceutical
  80. 6.14.1 Qi-hui Biopharmaceutical Company Information
  81. 6.14.2 Qi-hui Biopharmaceutical Business Overview
  82. 6.14.3 Qi-hui Biopharmaceutical Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Qi-hui Biopharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolio
  84. 6.14.5 Qi-hui Biopharmaceutical Recent Developments
  85. 6.15 SUNΛ Med-Engineering
  86. 6.15.1 SUNΛ Med-Engineering Company Information
  87. 6.15.2 SUNΛ Med-Engineering Business Overview
  88. 6.15.3 SUNΛ Med-Engineering Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 SUNΛ Med-Engineering Ultrasonic Microbubble Contrast Agents Product Portfolio
  90. 6.15.5 SUNΛ Med-Engineering Recent Developments
  91. 6.16 Starleaf
  92. 6.16.1 Starleaf Company Information
  93. 6.16.2 Starleaf Business Overview
  94. 6.16.3 Starleaf Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Starleaf Ultrasonic Microbubble Contrast Agents Product Portfolio
  96. 6.16.5 Starleaf Recent Developments
7 North America by Country
  1. 7.1 North America Ultrasonic Microbubble Contrast Agents Sales by Country
  2. 7.1.1 North America Ultrasonic Microbubble Contrast Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2026)
  4. 7.1.3 North America Ultrasonic Microbubble Contrast Agents Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ultrasonic Microbubble Contrast Agents Market Size by Country
  6. 7.2.1 North America Ultrasonic Microbubble Contrast Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ultrasonic Microbubble Contrast Agents Market Size by Country (2021-2026)
  8. 7.2.3 North America Ultrasonic Microbubble Contrast Agents Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ultrasonic Microbubble Contrast Agents Sales by Country
  2. 8.1.1 Europe Ultrasonic Microbubble Contrast Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2026)
  4. 8.1.3 Europe Ultrasonic Microbubble Contrast Agents Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ultrasonic Microbubble Contrast Agents Market Size by Country
  6. 8.2.1 Europe Ultrasonic Microbubble Contrast Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ultrasonic Microbubble Contrast Agents Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ultrasonic Microbubble Contrast Agents Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ultrasonic Microbubble Contrast Agents Sales by Country
  2. 9.1.1 Asia-Pacific Ultrasonic Microbubble Contrast Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ultrasonic Microbubble Contrast Agents Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size by Country
  6. 9.2.1 Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ultrasonic Microbubble Contrast Agents Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ultrasonic Microbubble Contrast Agents Sales by Country
  2. 10.1.1 South America Ultrasonic Microbubble Contrast Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2026)
  4. 10.1.3 South America Ultrasonic Microbubble Contrast Agents Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ultrasonic Microbubble Contrast Agents Market Size by Country
  6. 10.2.1 South America Ultrasonic Microbubble Contrast Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ultrasonic Microbubble Contrast Agents Market Size by Country (2021-2026)
  8. 10.2.3 South America Ultrasonic Microbubble Contrast Agents Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales by Country
  2. 11.1.1 Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ultrasonic Microbubble Contrast Agents Market Size by Country
  6. 11.2.1 Middle East and Africa Ultrasonic Microbubble Contrast Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ultrasonic Microbubble Contrast Agents Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ultrasonic Microbubble Contrast Agents Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ultrasonic Microbubble Contrast Agents Value Chain Analysis
  2. 12.1.1 Ultrasonic Microbubble Contrast Agents Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ultrasonic Microbubble Contrast Agents Production Mode & Process
  7. 12.2 Ultrasonic Microbubble Contrast Agents Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ultrasonic Microbubble Contrast Agents Distributors
  10. 12.2.3 Ultrasonic Microbubble Contrast Agents Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst